Today: 7 February 2026
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Autonomix Medical (AMIX) Stock Doubles on New Pancreatic Cancer Quality‑of‑Life Data – November 17, 2025 Update

Autonomix Medical (AMIX) Stock Doubles on New Pancreatic Cancer Quality‑of‑Life Data – November 17, 2025 Update

All of today’s Autonomix (AMIX) news in one glance – 17 November 2025 As of this afternoon on November 17, 2025, all company‑specific news about Autonomix Medical, Inc. (NASDAQ: AMIX) centers on the same core development: new quality‑of‑life data from its pancreatic cancer PoC 1 study and the stock’s reaction to it. The main headlines are: No additional Autonomix‑specific earnings reports, SEC filings or separate product announcements have been released today beyond coverage of this PoC 1 subgroup analysis and its market impact, based on public news and filings available at the time of writing. Last10K+1 What Autonomix announced today
17 November 2025
·
Michael Saylor’s Strategy Bets $835M on the Bitcoin Dip as Crypto Market Slides Below $95K

Michael Saylor’s Strategy Bets $835M on the Bitcoin Dip as Crypto Market Slides Below $95K

Bitcoin may be stuck in its deepest correction of 2025, but Michael Saylor is leaning in, not backing out. Over the past week, Strategy Inc. (MSTR) — the enterprise software company turned Bitcoin mega‑holder led by executive chairman Michael Saylor — acquired 8,178 BTC for about $835.6 million, its largest weekly buy since July.Bloomberg+1 At the same time, Saylor has a clear message for nervous investors watching Bitcoin bleed: HODL. Key facts at a glance Strategy’s Biggest Bitcoin Buy Since July According to a Monday filing with the U.S. Securities and Exchange Commission, Strategy disclosed that it had bought $835.6
17 November 2025
·
MSP Recovery (MSPR) Stock Jumps Over 20% Pre‑Market as Q3 Delay and Nasdaq Fight Keep Volatility High – 17 November 2025

MSP Recovery (MSPR) Stock Jumps Over 20% Pre‑Market as Q3 Delay and Nasdaq Fight Keep Volatility High – 17 November 2025

Important: This article is news and analysis, not investment advice. MSPR is a highly speculative micro‑cap; anyone considering it should do independent research and consider professional guidance. What’s Happening With MSPR Today (17 November 2025)? Pre‑market spike puts MSPR back on trader radars In the very early hours of Monday’s U.S. session, Benzinga’s pre‑market movers roundup flagged MSP Recovery as one of the most aggressive gainers in the market. At about 4:42 a.m. ET, the outlet reported MSPR up 38.6% to $0.6230 in pre‑market trading, noting that the stock had fallen roughly 5% on Friday. A few hours later, Benzinga’s
17 November 2025
··
Saab AB (SAAB-B.ST) Jumps on €3.1bn Gripen Colombia Deal as New Drone and Solar Partnerships Emerge – 17 November 2025

Saab AB (SAAB-B.ST) Jumps on €3.1bn Gripen Colombia Deal as New Drone and Solar Partnerships Emerge – 17 November 2025

Swedish defence and security group Saab AB (publ) (B‑share ticker SAAB‑B.ST) is firmly in the spotlight today after a wave of fighter‑jet contracts, electronic‑warfare orders and new technology partnerships pushed the stock sharply higher and sparked fresh debate about valuation and future growth. By mid‑afternoon on Monday, Saab’s B‑share was trading around SEK 555, up roughly 5–6% on the day and near its 52‑week high, leaving the OMXS30 benchmark in the dust. Year‑to‑date, the share has gained more than 120%, according to Saab’s own investor data and market feeds. Start+2MarketScreener+2 Below is a full rundown of the key Saab developments
17 November 2025
···
Sigma Lithium (SGML) Stock Soars in Premarket as Lithium Demand Hopes Collide With Q3 2025 Turnaround

Sigma Lithium (SGML) Stock Soars in Premarket as Lithium Demand Hopes Collide With Q3 2025 Turnaround

Sigma Lithium Corporation (NASDAQ: SGML, TSXV: SGML) is back on traders’ radar this Monday, with the stock ripping higher in premarket trading as investors react to a powerful mix of macro lithium news, fresh institutional buying and the company’s latest Q3 2025 results. SGML Stock Jumps More Than 30% in Premarket Trade Sigma Lithium is one of today’s standout premarket gainers in the U.S. market. These sharp moves come after SGML closed last session at $6.06 (Friday), already up about 2.7% on heavy volume of 8.29 million shares—more than double its recent average of 3.85 million. MarketBeat+1 In other words:
17 November 2025
···
Backbone Pro Xbox Edition: Price, Features, Release Date and Why It’s the New Go‑To Controller for Xbox Cloud Gaming (November 17, 2025)

Backbone Pro Xbox Edition: Price, Features, Release Date and Why It’s the New Go‑To Controller for Xbox Cloud Gaming (November 17, 2025)

Backbone Pro Xbox Edition is the latest “Designed for Xbox” mobile controller, blending full-size gamepad comfort with cross‑device Xbox Cloud Gaming support. Here’s everything you need to know today, November 17, 2025 – price, specs, compatibility, and early reactions. What is the Backbone Pro – Xbox Edition? Backbone’s new Pro – Xbox Edition is a premium, officially licensed Xbox controller designed to follow you from your phone to your TV, PC, tablet, laptop, and even VR headsets. It’s essentially a “console-grade” pad that can snap around your smartphone or work as a standalone wireless controller. Microsoft and Backbone first detailed
17 November 2025
Jazz Pharmaceuticals (JAZZ) Soars on Breakthrough Ziihera Phase 3 Results in Gastroesophageal Cancer – Key Updates for 17 November 2025

Jazz Pharmaceuticals (JAZZ) Soars on Breakthrough Ziihera Phase 3 Results in Gastroesophageal Cancer – Key Updates for 17 November 2025

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is in the spotlight today after announcing positive Phase 3 data for its cancer drug Ziihera® (zanidatamab‑hrii) in a large global trial for HER2‑positive gastroesophageal adenocarcinoma (GEA). The news has triggered sharp pre‑market moves in Jazz’s share price and its partners’ stocks, and could reshape the treatment landscape for a difficult‑to‑treat cancer. PR Newswire+1 JAZZ stock today: volatility after a major cancer win As of early afternoon U.S. trading on Monday, November 17, Jazz Pharmaceuticals shares are trading around $141.07, little changed on the day according to real‑time quote data. Earlier, however, markets reacted far
17 November 2025
·
Dragonfly Energy (DFLI) Stock Pops as Canaccord Hikes Price Target to $2.25 After Big Q3 Earnings Beat

Dragonfly Energy (DFLI) Stock Pops as Canaccord Hikes Price Target to $2.25 After Big Q3 Earnings Beat

Dragonfly Energy Holdings Corp. (NASDAQ: DFLI), the lithium battery technology company behind the Battle Born® brand, is back in the spotlight today after a powerful combination of an earnings surprise, an aggressive analyst upgrade and a sweeping balance sheet reset. Canaccord Genuity this morning more than doubled its 12‑month price target on Dragonfly Energy from $1.00 to $2.25 while reiterating a Buy rating, implying roughly 178% upside from around $0.81 per share.Investing.com The call lands just days after Dragonfly’s Q3 2025 results showed strong OEM growth, sharply higher gross margins and progress on debt reduction. In Monday trading, DFLI was
17 November 2025
··
Johnson & Johnson’s $3.05 Billion Halda Therapeutics Deal Signals New Oncology Push After Stelara Patent Cliff

Johnson & Johnson’s $3.05 Billion Halda Therapeutics Deal Signals New Oncology Push After Stelara Patent Cliff

Johnson & Johnson has struck a $3.05 billion cash deal to acquire Halda Therapeutics, a privately held cancer-drug developer based in New Haven, Connecticut, in one of 2025’s biggest oncology takeovers so far.Reuters+1 The move deepens J&J’s bet on cancer medicines just as sales of its long‑time blockbuster psoriasis drug Stelara are being hit hard by a wave of cheaper biosimilar rivals.Yahoo Finance+1 Key points Inside Johnson & Johnson’s Halda Therapeutics takeover J&J said on Monday that it will acquire Halda Therapeutics for $3.05 billion in cash, adding a new set of precision oncology assets to its Innovative Medicine unit.Reuters+1
17 November 2025
··
Interstellar Comet 3I/ATLAS: ESA Sharpens Its Path as December Flyby Fuels Livestreams and Debunks Doomsday Rumors

Interstellar Comet 3I/ATLAS: ESA Sharpens Its Path as December Flyby Fuels Livestreams and Debunks Doomsday Rumors

Interstellar comet 3I/ATLAS (C/2025 N1 ATLAS) – a frozen wanderer from another star system – is back in the news today as space agencies and observatories around the world fine‑tune its trajectory, release new images and prepare global livestreams ahead of its safe flyby of Earth in December 2025. At the same time, scientists are working hard to knock down viral claims that the comet is either an alien spacecraft or on a collision course with our planet. Spoiler: it’s neither. Here’s what you need to know today. What is 3I/ATLAS – and why is it such a big deal?
17 November 2025
Twin Vee PowerCats (VEEE) Stock Jumps in Premarket as Bahama Boats Roll Out: Latest News for 17 November 2025

Twin Vee PowerCats (VEEE) Stock Jumps in Premarket as Bahama Boats Roll Out: Latest News for 17 November 2025

On Monday morning, 17 November 2025, micro‑cap boat builder Twin Vee PowerCats Co. (NASDAQ: VEEE) popped up on traders’ screens as one of the day’s more volatile pre‑market movers. Multiple market outlets flagged the stock after it surged roughly 15–22% in early trading, hovering around the $2.00 level, before regular‑session trading pulled the price back toward the mid‑$1 range later in the day. Benzinga+1 The move comes just days after Twin Vee announced the start of customer deliveries for its newly acquired Bahama Boat Works brand and reported third‑quarter results that showed narrowing losses but continued cash burn. Twin Vee
17 November 2025
WeShop Holdings (NASDAQ: WSHP) Soars Again as Nasdaq Composite Adds New Social‑Commerce Stock – 17 November 2025 Update

WeShop Holdings (NASDAQ: WSHP) Soars Again as Nasdaq Composite Adds New Social‑Commerce Stock – 17 November 2025 Update

WeShop Holdings Limited’s Class A Ordinary Shares (NASDAQ: WSHP) are back in the spotlight today, 17 November 2025, as the newly listed social‑commerce stock rips higher in pre‑market trading and is added to the Nasdaq Composite Index just days after its debut. Below is a full rundown of everything that happened today around WSHP, and what it could mean for investors watching this fast‑moving name. WSHP Stock Today: Pre‑Market Moves Near +90–100% WeShop’s first regular trading session on Friday, 14 November, ended with the stock at $30.21, up 91.99% from its reference price, after trading between $20.02 and $39.22 during
17 November 2025
·
1 … 38 39 40 41 42 … 233

Stock Market Today

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

7 February 2026
Kenvue shares closed Friday at $18.13, up 0.33%, with about 63.5 million shares traded. The Kimberly-Clark offer values Kenvue at roughly $18.76 per share, leaving a deal spread of about 3%. Both companies’ shareholders approved the merger, which is expected to close in the second half of 2026 pending regulatory approvals. Kenvue’s dividend record date is Feb. 11, with earnings due Feb. 17.
Go toTop